Company profile
UK company 02419461, incorporated on 4 September 1989.
Pion - Leader in Next-Gen Pharma Development
Unique Instruments and Services that Help Scientists Make Informed Decisions About Food and Drug Formulation from R&D to Manufacturing
Company number 02419461
Reference milestones and recent Companies House filing stream events.
AA | Transaction MzUzODUyMjc2NGFkaXF6a2N4 | Paper/PDF filed
Published 20 Aug 2026 23:11
Company registered at Companies House
1 Jan 2015 to 31 Dec 2015
Tens of thousands of animals are sacrificed every year in the UK during drug toxicity testing; many more worldwide. Toxicity testing is an important part of drug development. Newly discovered molecules are tested, as well as metabolites and new formulations. The tests are generally done on rats, mice and dogs. Many of these tests are not actually done to ...
1 Aug 2013 to 30 Jun 2014
Our goal is to build a new instrument that can be used by pharmaceutical scientists to investigate formulations of “small molecule” drugs. The active pharmaceutical ingredients (APIs) in most drugs on the market today are organic compounds with molecular weight of 500 or less which interact with receptors in the human body to produce a desired therapeutic...
1 Aug 2013 to 31 Jan 2015
We want to build an instrument to simulate what happens at the site of injection when a drug is administered subcutaneously into the human body. The instrument will be used to test newformulations, and to control the quality of manufactured batches of existing products. Many new drugs are biopharmaceuticals, such as proteins or peptides. Due to poor stabi...
